Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-05-19 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-05-19 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-05-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "INDIVIOR PLC TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares for cancellation on May 16, 2024. It provides specific details on the number of shares purchased, the highest, lowest, and VWAP prices, and a full breakdown of individual transactions. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). The RNS Number and date suggest it is a regulatory disclosure, but the specific content points strongly to POS over the general RNS fallback.
2024-05-17 English
INDIVIOR TO PARTICIPATE IN UPCOMING EVENTS
Regulatory Filings
2024-05-16 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-05-16 English
Indivior to Participate in Upcoming Events
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3446 characters) distributed via RNS (Regulatory News Service) on May 16, 2024. The content explicitly states that Indivior PLC will 'participate in the following investor events' (Craig-Hallum Conference and Jefferies Global Healthcare Conference) and provides details about management presentations and meetings. This is not a full financial report (like 10-K or IR), nor is it a specific announcement about dividends, director dealings, or capital changes. It is an announcement about future investor engagement, which fits best under the general regulatory announcement category, RNS, as it is a standard market communication disseminated through the official news service.
2024-05-16 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.